Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01694940 · ClinicalTrials.gov registry record
North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)
A clinical trial of Mitochondrial Diseases and Mitochondrial Disorders, sponsored by Columbia University.
- Recruiting
- Registry status
- 1,000
- Enrollment target
- 17
- Study locations
NCT01694940 is a study of Mitochondrial Diseases and Mitochondrial Disorders that is actively recruiting participants, run by Columbia University. The registered enrollment target is 1,000 participants, above the 134-participant average among 7 other Mitochondrial Diseases trials with a reported enrollment target (646% higher). The trial reports 17 study locations across 12 states.
The verdict
NCT01694940, a study of Mitochondrial Diseases and Mitochondrial Disorders, is actively recruiting participants, sponsored by Columbia University.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 17
- Study locations
Study Summary
The North American Mitochondrial Disease Consortium (NAMDC) maintains a patient contact registry and tissue biorepository for patients with mitochondrial disorders.
Conditions Studied
Study Locations (17)
Ohio
- Akron Children's Hospital - Akron
- Cleveland Clinic - Cleveland
- Case Western Reserve University - Clevland
California
- University of California San Diego - San Diego
- Lucile Packard Children's Hospital - Stanford
New York
- Columbia University Medical Center - New York
- Virtual Site (Remote enrollment) - New York
Pennsylvania
- The Children's Hospital of Philadelphia - Philadelphia
- Children's Hospital of Pittsburgh - Pittsburgh
Colorado
- Children's Hospital of Colorado - Aurora
District of Columbia
- Children's National Medical Center - Washington D.C.
Florida
- University of Florida - Gainsville
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2011-01-31 |
| Est. Completion | 2026-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01694940
The ClinicalTrials.gov registry entry for NCT01694940 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 134-participant average among 7 other Mitochondrial Diseases trials with a reported enrollment target (646% higher). The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Mitochondrial Diseases appearing as the primary indexed condition, and to 0 interventions.
NCT01694940 reports 17 study locations spanning 12 distinct geographic areas - top geographies include Ohio, California, New York.
Frequently Asked Questions
What is clinical trial NCT01694940 about?
NCT01694940 is a clinical study titled "North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)". The North American Mitochondrial Disease Consortium (NAMDC) maintains a patient contact registry and tissue biorepository for patients with mitochondrial disorders.
What is the current status of trial NCT01694940?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2011-01-31. Estimated completion is 2026-12-31.
What conditions does trial NCT01694940 study?
This clinical trial studies the following conditions: Mitochondrial Diseases, Mitochondrial Disorders, Mitochondrial Genetic Disorders, Disorder of Mitochondrial Respiratory Chain Complexes, Deletion and Duplication of Mitochondrial DNA.
Who is sponsoring clinical trial NCT01694940?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01694940 being conducted?
This trial has 17 study locations across California, Colorado, District of Columbia, Florida, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Mitochondrial Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Validation of Oxygen Nanosensor in Mitochondrial Myopathy
RECRUITING · Phase 1
-
KHENERFIN Study: A Trial to Evaluate the Efficacy and Safety of Sonlicromanol in Primary Mitochondrial Diseases
RECRUITING · Phase 3
-
Applying pGz in Mitochondrial Disease
RECRUITING · Phase 1
-
Transgenerational Metabolic-Immune Biomarkers of Neurological and Neurodevelopmental Disorders
RECRUITING
-
Phase III Trial of Coenzyme Q10 in Mitochondrial Disease
COMPLETED · Phase 3
-
Heart Rate Variability in Response to Metformin Challenge
COMPLETED · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.